精品黑人巨大在线一区,91人妻人人做人人爽九色全集,手机在线免费国产精品,日韩另类av中文字幕,亚洲最大在线精品,久久九九精品免费看,伊人久久久最新网址,99久久在线精品视频,中文久久久久久久

丹參酮IIA

分析標(biāo)準(zhǔn)品,HPLC≥98%

Tanshinone IIA

CAS號：568-72-9

分子式：C19H18O3

分子量：294.34

MDL：MFCD00238692

產(chǎn)品介紹

熔點(diǎn)：205-207℃

沸點(diǎn)：480.7℃ at 760 mmHg

外觀：桔紅色針狀結(jié)晶

溶解性：按照順序添加:5%  DMSO+30%  PEG  300+2%  Tween  80+ddH2O。此方法可以溶解0.2mg/ml。丹參酮IIA溶液狀態(tài)下不穩(wěn)定，需要現(xiàn)配現(xiàn)用，不能儲備液形式儲存。

儲存條件：2-8℃

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

參考文獻(xiàn)(106篇)

106. [IF=10.2] Chenjie Xia et al."An efficient brain delivery system co-loaded with multiple components of Salvia miltiorrhiza for synergistic treatment of ischemic stroke."Materials Today Bio.2025 Jul;:102102

105. [IF=3.4] Wang Qiaona et al."Anti-oxidative effect of Salvia miltiorrhiza Bunge fermented with Shiraia bambusicola Henn. against H2O2-induced injury in PC12 cells."BMC Complementary Medicine and Therapies.2025 Dec;25(1):1-13

104. [IF=4] Lijuan Wu et al."Integration of chromatographic fractionation, quantitative 1H-NMR and serially coupled achiral-chiral LC–MS/MS enables multi-components-targeted determination of Salvia miltiorrhiza in an authentic compound-independent manner."JOURNAL OF

103. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253

102. [IF=5.7] Xue-Zhang et al."Discovery of Tetrahydro Tanshinone I as a Naturally Occurring Covalent Pan-Inhibitor Against Gut Microbial Bile Salt Hydrolases."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2024;XXXX(XXX):XXX-XXX

101. [IF=6.7] Mingzhu Qi et al."Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis."PHYTOMEDICINE.2024 Dec;135:156147

100. [IF=5.7] Lichao Qian et al."In silico identification and verification of Tanshinone IIA-related prognostic genes in hepatocellular carcinoma."Frontiers in Immunology.2024 Oct;15:

99. [IF=8.3] Ruiyan Zhu et al."Abscisic acid enhances SmAPK1-mediated phosphorylation of SmbZIP4 to positively regulate tanshinone biosynthesis in Salvia miltiorrhiza."NEW PHYTOLOGIST.2024 Nov;:

98. [IF=8.1] Sheng Wang et al."Target-oriented rational design of composite bio-derived solvents for the green extraction of salvianolic acid B and tanshinones from Salvia miltiorrhiza root."SEPARATION AND PURIFICATION TECHNOLOGY.2025 Jun;359:130772

97. [IF=3.8] Xu Wang et al."A HPLC-assisted mathematical prediction method of ternary solvent systems to develop an intelligent online selection system for countercurrent chromatography solvent system."JOURNAL OF CHROMATOGRAPHY A.2024 Dec;:465585

96. [IF=4.8] Zhirong Zhou et al."Dan-Shen-Yin against ethanol-induced chronic gastric mucosal injury in rats by inhibiting apoptosis via IP3R-controlled calcium release."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jan;:119413

95. [IF=4.8] Ke Cai et al."Absorption and metabolic transformation mechanisms of the interaction between salvianolic acids and tanshinones in DKD rats."JOURNAL OF ETHNOPHARMACOLOGY.2025 May;348:119885

94. [IF=11.4] Keqin Lu et al."Synergistic potentiation of the anti-metastatic effect of a Ginseng-Salvia miltiorrhiza herbal pair and its biological ingredients via the suppression of CD62E-dependent neutrophil infiltration and NET formation."Journal of Advanced Resear

93. [IF=4.8] Wencong Tian et al."Tanshinone IIA, a Component of Salvia miltiorrhiza Bunge, Attenuated Sepsis-induced Liver Injury via the SIRT1/Sestrin2/HO-1 Signaling Pathway."JOURNAL OF ETHNOPHARMACOLOGY.2024 Nov;:119169

92. [IF=5.3] Yao Chen et al."Biomimetic metal-phenolic nanocarrier for co-delivery of multiple phytomedical bioactive components for anti-atherosclerotic therapy."INTERNATIONAL JOURNAL OF PHARMACEUTICS.2025 Jan;:125228

91. [IF=4.7] Jinpeng Sun et al."Network Pharmacology, Molecular Docking, and in vitro Experiments Reveal the Role and Mechanism of Tanshinone IIA in Colorectal Cancer Treatment Through the PI3K/AKT Pathway."Drug Design Development and Therapy.

90. [IF=3.5] Yuanjie Wu et al."Tanshinone IIA Combined With Rutin and Squalene Improves Hyperlipidemia to Alleviate Atherosclerosis in New Zealand Rabbits Through Upregulation of the SREBP2/LDLR Pathway."JOURNAL OF FOOD BIOCHEMISTRY.2025 Apr;2025(1):8349248

89. [IF=0.6] Hui Dong et al."Research on the Improvement of Endothelial Cell Function and Trophoblast Apoptosis in Rats with Preeclampsia by Tanshinone IIA."Pharmacognosy Magazine.;():

88. [IF=2.6] Yan-Zhu Quan et al."The intervention mechanism of Tanshinone IIA in alleviating neuronal injury induced by HMGB1 or TNF-α-mediated microglial activation."TOXICOLOGY IN VITRO.2024 Dec;101:105950

87. [IF=3.8] Xiu-mei Luan et al."Improvement of polarity-based solvent system for countercurrent chromatography in the guidance of solvent selectivity: n-hexane/ethyl acetate/ alcohol solvents/water as an example."JOURNAL OF CHROMATOGRAPHY A.2024 Nov;1736:465389

86. [IF=4.9] Zhongda Cao et al."Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2024 Jan;25(18):9930

85. [IF=4.8] Zhengchao Ji et al."Holistic quality assessment and monitoring of YiXinShu capsule based on three-dimensional fingerprints combined with quantitative analysis, antioxidant activity and chemometrics."JOURNAL OF ETHNOPHARMACOLOGY.2024 Dec;335:118630

84. [IF=13.3] Zhicheng Xiao et al."A novel nitric oxide-driven nanomotor for synergistic treatment of ischaemic stroke: Enhanced deep brain penetration and therapeutic efficacy."CHEMICAL ENGINEERING JOURNAL.2024 Sep;496:154205

83. [IF=2.8] Fang Liang et al."Therapeutic effects of Tanshinone IIA and Tetramethylpyrazine nanoemulsions on cognitive impairment and neuronal damage in Alzheimer’s disease rat models."JOURNAL OF PHARMACY AND PHARMACOLOGY.2024 Jun;:

82. [IF=6.2] Ying Ren et al."Effect of CeO2, TiO2 and SiO2 nanoparticles on the growth and quality of model medicinal plant Salvia miltiorrhiza by acting on soil microenvironment."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY.2024 Jul;280:116552

81. [IF=2.6] Cheng Shao et al."Local Application of Tanshinone IIA protects mesenchymal stem cells from apoptosis and promotes fracture healing in ovariectomized mice."Journal of Orthopaedic Surgery and Research".2024 Dec;19(1):1-12

80. [IF=2.6] Fan Yang et al."Preliminary Exploration of Potential Active Ingredients and Molecular Mechanisms of Yanggan Yishui Granules for Treating Hypertensive Nephropathy Using UPLC-Q-TOF/MS Coupled with Network Pharmacology and Molecular Docking Strategy."Journal

79. [IF=7.9] Mingyu Wu et al."Tanshinone IIA positively regulates the Keap1-Nrf2 system to alleviate pulmonary fibrosis via the sestrin2-sqstm1 signaling axis-mediated autophagy."PHYTOMEDICINE".2024 Apr;:155620

78. [IF=10.2] Guo Hong et al."Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor."JOURNAL OF NANOBIOTECHNOLOGY".2024 Dec;22(1):1-20

77. [IF=1.8] Meile Ma et al."Tanshinone IIA Regulates Synaptic Plasticity in Mg2+-Free-Induced Epileptic Hippocampal Neurons via the PI3K/Akt Signaling Pathway."Journal of Integrative Neuroscience".2024 Mar;23(3):61

76. [IF=9.8] Ying Ren et al."Response of antioxidant activity, active constituent and rhizosphere microorganisms of Salvia miltiorrhiza to combined application of microbial inoculant, microalgae and biochar under Cu stress."SCIENCE OF THE TOTAL ENVIRONMENT".2024 May;9

75. [IF=1.1] Ji-Yong FU et al."Simultaneous determination of 19 constituents in the Jian-Nao-Ning mixture using high-performance liquid chromatography-tandem mass spectrometry."Separation Science Plus".2024 Feb;:2300222

74. [IF=6] Honglin Liu et al."Tanshinone IIA as a therapy for PCOS via FOS/JUN/TP53 axis: Evidence from network pharmacology of Bajitian-Danshen pair."Arabian Journal of Chemistry".2024 Feb;:105641

73. [IF=10.7] Baixi Shan et al."Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-13C5]-glutamine metabolic flux analysis."Journal of Advanced Research".2024 May;:

72. [IF=4.7] Xu Zhang et al."Rhein: A potent immunomodulator empowering largemouth bass against MSRV infection."FISH & SHELLFISH IMMUNOLOGY.2024 Jan;144:109284

71. [IF=7.5] Xiangke Ma et al."Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2."BIOMEDICINE & PHARMACOTHERAPY.10.1016/j.biopha.2023.115501

70. [IF=8.8] Baixi Shan et al."Tanshinone II ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis."Journal of Pharmaceutical Analysis.10.1016/j.jpha.2023.09.008

69. [IF=5] Ning Liu et al."Sulfonated azocalix[4]arene-Tanshinone IIA supramolecular drug delivery system based on hypoxic reduction response for treatment of ischemic heart disease: Enhance the solubility, stability and bioavailability of drugs."JOURNAL OF DRUG DEL

68. [IF=10.2] Ying Zhang et al."Phytoestrogen-derived multifunctional ligands for targeted therapy of breast cancer."Asian Journal of Pharmaceutical Sciences.2023 Jul;:100827

67. [IF=3.1] Cuicui Liu et al."Identification and quantitative analysis of the chemical constituents of Gandouling tablets using ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry."JOURNAL OF SEPARATION SCIENCE.2023 Jun;:2300

66. [IF=4.6] Yun Zhang et al."G-Quadruplexes Formation by the C9orf72 Nucleotide Repeat Expansion d(GGGGCC)n and Conformation Regulation by Fangchinoline."MOLECULES.2023 Jan;28(12):4671

65. [IF=5.7] Pan Shuangjia et al."Tanshinone IIA changed the amniotic fluid volume and regulated expression of AQP1 and AQP3 in amniotic epithelium cells: a promising drug treating abnormal amniotic fluid volume."MOLECULAR MEDICINE.2023 Dec;29(1):1-14

64. [IF=5.195] Jingwen Xu et al."Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis."JOURNAL OF ETHNOPHARMACOLOGY.2023 May;:116675

63. [IF=3.97] Xin Zhang et al."Nano-encapsulated tanshinone IIA in PLGA-PEG-COOH inhibits apoptosis and inflammation in cerebral ischemia/reperfusion injury."Green Processing and Synthesis.2023 Jan;12(1):

62. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396

61. [IF=0] Yanshan Zhan et al."Preparation of tanshinone IIA self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts."Chinese Herbal Medicines.2023 Jan;:

60. [IF=6.208] Huan Zhao et al."Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(23):15180

59. [IF=7.033] Junwei Gao et al."Peptide-Based HDL as an Effective Delivery System for Lipophilic Drugs to Restrain Atherosclerosis Development."International Journal of Nanomedicine.2022 Sep;17:3877-3892

58. [IF=6.317] Ping Huang et al."Optimization of smashing tissue and ultrasonic extraction of tanshinones and their neuroprotective effect on cerebral ischemia/reperfusion injury by inhibiting parthanatos."Food & Function.2022 Aug;:

57. [IF=6.388] Yong-li Jiang et al."Tanshinone IIA improves contextual fear- and anxiety-like behaviors in mice via the CREB/BDNF/TrkB signaling pathway."PHYTOTHERAPY RESEARCH

56. [IF=4.051] Shao Hailing et al."Tanshinone IIA increased amniotic fluid volume through down-regulating placental AQPs expression via inhibiting the activity of GSK-3β."CELL AND TISSUE RESEARCH.2022 Jun;:1-12

55. [IF=6.627] Jiadong Hu et al."Identification of Abietane-Type Diterpenoids and Phenolic Acids Biosynthesis Genes in Salvia apiana Jepson Through Full-Length Transcriptomic and Metabolomic Profiling."Frontiers in Plant Science.2022; 13: 919025

54. [IF=2.63] Li Hangchao et al."Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway."Evidence-based Complementary and Alternative Medicine. 2022;2022:

53. [IF=7.376] Chengtao Sun et al."Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation."Free Radical Bio Med. 2022 Feb;180:220

52. [IF=4.432] Xiaoqian Peng et al."Tanshinone IIA regulates glycogen synthase kinase-3β-related signaling pathway and ameliorates memory impairment in APP/PS1 transgenic mice."Eur J Pharmacol. 2022 Mar;918:174772

51. [IF=2.629] Zhu Yinxing et al.PEI-PEG-Coated Mesoporous Silica Nanoparticles Enhance the Antitumor Activity of Tanshinone IIA and Serve as a Gene Transfer Vector.Evid-Based Compl Alt. 2021;2021:6756763

50. [IF=6.057] Qi Tong et al.Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.Talanta. 2021 Nov;:123045

49. [IF=2.055] Qian Chen et al."Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota."J Nat Med-Tokyo. 2021 Jan;75(1):84-98

48. [IF=2.1] Guofang  Guan et al."Identifying the mechanisms underlying the protective effect of tetramethylpyrazine against cisplatin?induced in vitro ototoxicity in HEI?OC1 auditory cells using gene expression profiling."Mol Med Rep. 2020 Dec;22(6):5053-5068

47. [IF=3] Qu  Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

46. [IF=3.411] Liu Hongyan et al."Effect Study of Continuous Monoculture on the Quality of Salvia miltiorrhiza Bge Roots."Biomed Res Int. 2020;2020:4284385

45. [IF=3.434] Du Xiaoxun et al."Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells."Dis Markers. 2021;2021:6554480

44. [IF=3.682] Xiao-Wei Zhang et al."Lipophilic Extract and Tanshinone IIA Derived from Salvia miltiorrhiza Attenuate Uric Acid Nephropathy through Suppressing Oxidative Stress-Activated MAPK Pathways."Am J Chinese Med. 2020 Sep;48(06):1455-1473

43. [IF=3.69] Ke-Yu Peng et al."Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice."J Ethnopharmacol. 2021 Jan;264:113052

42. [IF=3.69] Miao-Juan Shi et al."A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis."J Ethnopharmacol. 2020 May;253:112689

41. [IF=3.69] Qian Zhang et al."Qishen Granule alleviates endoplasmic reticulum stress-induced myocardial apoptosis through IRE-1-CRYAB pathway in myocardial ischemia."J Ethnopharmacol. 2020 Apr;252:112573

40. [IF=3.881] Yingying He et al."Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice."Neurochem Int. 2020 Feb;133:104610

39. [IF=4.411] Yuanyuan Li et al."Quantitative Determination and Validation of Four Ketones in Salvia miltiorrhiza Bunge Using Quantitative Proton Nuclear Magnetic Resonance Spectroscopy."Molecules. 2020 Jan;25(9):2043

38. [IF=5.793] Ding  Bo et al."Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro."J Neuroinflamm. 2020 Dec;17(1):1-17

37. [IF=5.875] Zhe Li et al."Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia."Int J Pharmaceut. 2020 Aug;586:119576

36. [IF=6.475] Shi Qiu et al."Selection of appropriate post-harvest processing methods based on the metabolomics analysis of Salvia miltiorrhiza Bunge."Food Res Int. 2021 Jun;144:110366

35. [IF=6.988] Michael  et al."Like Dissolves Like? A Comprehensive Evaluation of Partial Solubility Parameters to Predict Polymer–Drug Compatibility in Ultrahigh Drug-Loaded Polymer Micelles."Biomacromolecules. 2019;20(8):3041–3056

34. [IF=7.514] Tong Wang et al."A hydrophobic deep eutectic solvents-based integrated method for efficient and green extraction and recovery of natural products from Rosmarinus officinalis leaves, Ginkgo biloba leaves and Salvia miltiorrhiza roots."Food Chem. 2021 Nov;3

33. [IF=1.863] Ligang Jie et al."Tanshinone IIA induces apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis via blockade of the cell cycle in the G2/M phase and a mitochondrial pathway."Biological & Pharmaceutical Bulletin. 2014 Jun 11

32. [IF=7.514] Tiehua Zhang et al."In vitro and in silico perspectives on estrogenicity of tanshinones from Salvia miltiorrhiza."Food Chem. 2019 Jan;270:281

31.  Miao-Juan Shi, Xiu-Li Yan, Ben-Sheng Dong, Wen-Na Yang, Shi-Bing Su, Hui Zhang,

A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis,

Journal of Ethnopharmacology,

Volume 253,

2020,

112689,

IS

30.  Li, Zhe, et al. "Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia." International Journal of Pharmaceutics 586 (2020): 119576.https:##doi.org

29.  Lu?btow, Michael M., et al. "Like dissolves like? A comprehensive evaluation of partial solubility parameters to predict polymer–drug compatibility in ultrahigh drug-loaded polymer micelles." Biomacromolecules 20.8 (2019): 3041-3056.https:##doi.org/10.1021

28.  Yang, Runyu, et al. "Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1." Phytomedicine 69 (2020): 153211.https:##doi.org/10.1016/j.phymed.2020

27.  Ding, B., Lin, C., Liu, Q. et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation 17, 302 (2020). https:##doi.org/10.1186/s12974-020-01981-4

26.  Li, Zhe, et al. "Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA." Artificial cells, nanomedicine, and biotechnology 46.sup1 (2018): 578-587.https:##doi.org/1

25.  何珊,付先軍,張玲,彭霄,王振國.響應(yīng)面法優(yōu)化丹參有效成分的提取工藝及其體外抗氧化活性研究[J].中華中醫(yī)藥學(xué)刊,2021,39(01):28-32+266-267.

24.  黑小斌,李歡,李慧,梁小燕,高靜,彭亮,李依民,張崗.丹參無菌培養(yǎng)體系構(gòu)建及有效成分含量的HPLC分析[J].中草藥,2020,51(22):5833-5838.

23.  喬羽君,賈晨,曹愛佳,張睿,華璽,焦海勝.丙戊酸鈉對丹參酮ⅡA在癲癇大鼠體內(nèi)藥動學(xué)的影響[J].現(xiàn)代中藥研究與實(shí)踐,2020,34(06):31-35.

22.  崔偉亮. 丹參酒炙前后HPLC指紋圖譜色譜峰歸屬比較[J]. 遼寧中醫(yī)雜志, v.46;No.507(08):1707-1709.

21.  王蕓, 陳軍峰, 張磊,等. 基于"有效成分-性狀"的關(guān)聯(lián)分析評價丹參品質(zhì)的研究[J]. 世界科學(xué)技術(shù):中醫(yī)藥現(xiàn)代化, 2019(5):835-843.

20.  敏敏  趙志國  劉偉 等. HPLC-DAD法同時測定三種來源丹參飲片中水溶性和脂溶性成分[J]. 山東科學(xué)  2019(6).

19.  牛敏  劉紅燕  劉謙 等. 4個栽培年限丹參顏色與9種活性成分含量的相關(guān)性[J]. 中成藥  2017(1):131-135.

18.  尉廣飛  李佳  劉謙 等. 丹參根部顏色及其與活性成分含量的相關(guān)性研究[J]. 山東農(nóng)業(yè)科學(xué)  2015(08):59-62.

17.  尉廣飛  劉謙  李佳 等. 丹參根部活性成分分布規(guī)律研究[J]. 山東科學(xué)  2015  28(05):7-13.

16.  梁從蓮  張永清  李佳 等. 不同株系丹參有效成分比較研究[J]. 山東科學(xué)  2018(4):31-38.

15.  支旭然  劉洪濤  吳茵 等. UPLC-MS/MS法同時測定腎康注射液中7個有效成分[J]. 藥物分析雜志  2017  037(001):37-42.

14.  李翠, 尉廣飛, 李佳,等. 性狀異常丹參的利用價值研究[J]. 山東科學(xué), 2014, 27(002):39-43.

13.  尉廣飛  李翠  劉謙 等. 丹參根部直徑與其活性成分含有量間的相關(guān)性研究[J]. 中成藥  2015  37(008):1780-1784.

12.  閆妍 石磊 史寧 郭宏舉 耿帥 溫彬宇.UPLC-Q-TOF-MS同時測定天王補(bǔ)心片中丹參的主要成分[J].解放軍藥學(xué)學(xué)報 2018 34(01):55-57.

11.  曹張琦,徐靜汶,路莉,胡燕,羅臻,李鴻源,王學(xué)習(xí).扶正通絡(luò)顆粒質(zhì)量標(biāo)準(zhǔn)研究[J].中國新藥雜志,2019,28(11):1372-1377.

10.  張玉, 戚瑩雪, 王蕾,等. 山東丹參脂溶性成分的地域分布特點(diǎn)研究[J]. 中藥材, 2018, 041(011):2522-2526.

9.  張芮乾,吳曉毅,胡添源,宋雅迪,高偉,黃璐琦.基于丹參酮類化合物生源途徑的丹參質(zhì)量標(biāo)志物研究思路探討[J].中國中藥雜志,2020,45(13):3098-3103.

8.  馬東來 劉愛朋 林悅 謝赟 劉濤 朱峰莉 楚立.丹參有效成分與鐵離子的相互作用[J].廣州化工 2017 45(14):117-118+144.

7.  溫靜, 唐雪陽, 李煥娟,等. 基于藥物體系質(zhì)量評價模式的丹參質(zhì)量表征關(guān)聯(lián)分析研究[J]. 中華中醫(yī)藥學(xué)刊, 2015, 033(004):843-846.

6.  劉蕾,楊玉潔,王凌,蔣學(xué)華.在“三明治"培養(yǎng)大鼠原代肝細(xì)胞中研究利福平及聯(lián)用丹參酮ⅡA對普伐他汀經(jīng)BSEP轉(zhuǎn)運(yùn)的影響[J].中國藥理學(xué)通報,2019,35(07):978-985.

5.  李敏  周靜  虞立 等. 丹參酮ⅡA提取工藝的優(yōu)化[J]. 中成藥  2018  040(003):741-744.

4.  趙麗萍  張琳成  陳冰 等. 丹參酮ⅡA對腦缺血再灌注損傷大鼠神經(jīng)保護(hù)作用的研究[J]. 中華中醫(yī)藥學(xué)刊  2019(9).

3.  王紅艷  蔡凡  徐春亮 等. 丹參酮ⅡA對內(nèi)皮細(xì)胞環(huán)氧合酶2表達(dá)的影響及相關(guān)機(jī)制[J]. 中國動脈硬化雜志  2014  22(010):997-1000.

2.  蘇志彩 邵蔚 張芳玲.丹參酮ⅡA對N-甲基-D-天冬氨酸誘導(dǎo)的視網(wǎng)膜神經(jīng)節(jié)細(xì)胞損傷的保護(hù)作用[J].實(shí)用老年醫(yī)學(xué) 2018 32(11):1009-1012.

1.  吳瑤  宋囡  賈連群 等. 丹參酮ⅡA對ApoE?/?小鼠肝臟脂質(zhì)沉積及鐵死亡相關(guān)蛋白表達(dá)的影響[J]. 中國病理生理雜志 2020年36卷7期  1261-1268頁  ISTIC PKU CSCD CA  2020.

從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!

如果您受時間、試驗(yàn)條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。

實(shí)驗(yàn)技術(shù)服務(wù)：